Agilent Technologies (AG8) Stock Overview
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for AG8 from our risk checks.
AG8 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Agilent Technologies, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$126.82 |
| 52 Week High | US$146.36 |
| 52 Week Low | US$87.00 |
| Beta | 1.26 |
| 1 Month Change | 5.53% |
| 3 Month Change | 27.55% |
| 1 Year Change | 1.39% |
| 3 Year Change | -7.17% |
| 5 Year Change | 31.52% |
| Change since IPO | 493.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| AG8 | DE Life Sciences | DE Market | |
|---|---|---|---|
| 7D | 1.0% | -0.9% | -1.6% |
| 1Y | 1.4% | -15.6% | 13.0% |
Return vs Industry: AG8 exceeded the German Life Sciences industry which returned -15.6% over the past year.
Return vs Market: AG8 underperformed the German Market which returned 13% over the past year.
Price Volatility
| AG8 volatility | |
|---|---|
| AG8 Average Weekly Movement | 4.5% |
| Life Sciences Industry Average Movement | 5.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 12.4% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: AG8 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: AG8's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 18,000 | Padraig McDonnell | www.agilent.com |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Agilent Technologies, Inc. Fundamentals Summary
| AG8 fundamental statistics | |
|---|---|
| Market cap | €35.97b |
| Earnings (TTM) | €1.06b |
| Revenue (TTM) | €5.88b |
Is AG8 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AG8 income statement (TTM) | |
|---|---|
| Revenue | US$6.79b |
| Cost of Revenue | US$3.22b |
| Gross Profit | US$3.57b |
| Other Expenses | US$2.35b |
| Earnings | US$1.22b |
Last Reported Earnings
Jul 31, 2025
Next Earnings Date
Nov 24, 2025
| Earnings per share (EPS) | 4.30 |
| Gross Margin | 52.58% |
| Net Profit Margin | 17.97% |
| Debt/Equity Ratio | 53.5% |
How did AG8 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/03 14:51 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2025/07/31 |
| Annual Earnings | 2024/10/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Agilent Technologies, Inc. is covered by 38 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Catherine Ramsey Schulte | Baird |
| Luke Sergott | Barclays |
| Charles Butler | Barclays |